Madrigal Pharmaceuticals Inc’s recently made public that its Director CRAVES FRED B unloaded Company’s shares for reported $2.56 million on Mar 12 ’25. In the deal valued at $331.84 per share,7,728 shares were sold. As a result of this transaction, CRAVES FRED B now holds 350,076 shares worth roughly $108.71 million.
Then, CRAVES FRED B sold 7,742 shares, generating $2,518,053 in total proceeds. Upon selling the shares at $325.25, the Director now owns 350,076 shares.
Before that, FRED CRAVES bought 7,742 shares. Madrigal Pharmaceuticals Inc shares valued at $2,518,054 were divested by the Director at a price of $325.25 per share.
B. Riley Securities upgraded its Madrigal Pharmaceuticals Inc [MDGL] rating to a Buy from a a Neutral in a research note published on February 28, 2025; the price target was increased to $422 from $236. A number of analysts have revised their coverage, including H.C. Wainwright’s analysts, who remained covering the stock and in late February has reiterated a ‘”a Buy”‘ rating for it. Cantor Fitzgerald began covering MDGL with “Neutral” recommendation on June 28, 2024. Wolfe Research started covering the stock on June 11, 2024. It rated MDGL as “an Outperform”.
Price Performance Review of MDGL
On Monday, Madrigal Pharmaceuticals Inc [NASDAQ:MDGL] saw its stock fall -1.23% to $310.52. Over the last five days, the stock has lost -6.25%. Madrigal Pharmaceuticals Inc shares have risen nearly 0.63% since the year began. Nevertheless, the stocks have risen 28.60% over the past one year. While a 52-week high of $377.46 was reached on 02/26/25, a 52-week low of $189.00 was recorded on 01/15/25. SMA at 50 days reached $333.15, while 200 days put it at $288.26.
Levels Of Support And Resistance For MDGL Stock
The 24-hour chart illustrates a support level at 293.48, which if violated will result in even more drops to 276.45. On the upside, there is a resistance level at 324.57. A further resistance level may holdings at 338.63. The Relative Strength Index (RSI) on the 14-day chart is 40.81, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -14.66, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 66.63%. Stochastics %K at 29.53% indicates the stock is a holding.
How much short interest is there in Madrigal Pharmaceuticals Inc?
A steep rise in short interest was recorded in Madrigal Pharmaceuticals Inc stocks on 2025-03-14, growing by 0.3 million shares to a total of 4.09 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 3.8 million shares. There was a rise of 7.3%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on April 22, 2024 when BofA Securities began covering the stock and recommended ‘”an Underperform”‘ rating along with a $150 price target.
